Category: Pharmaceuticals
Pharmaceuticals market research reports by GlobalData
-
Muscle Invasive Bladder Cancer (MIBC) - Global Clinical Trials Review, 2024
Muscle Invasive Bladder Cancer (MIBC) - Global Clinical Trials Review, 2024 Summary GlobalData's clinical trial report, “Muscle Invasive Bladder Cancer (MIBC) - Global Clinical Trials Review, 2024 provides an overview of Muscle Invasive Bladder Cancer (MIBC) Clinical trials scenario. This report pro ... Read More
-
Diabetic Nephropathy - Global Clinical Trials Review, 2024
Diabetic Nephropathy - Global Clinical Trials Review, 2024 Summary GlobalData's clinical trial report, “Diabetic Nephropathy - Global Clinical Trials Review, 2024 provides an overview of Diabetic Nephropathy Clinical trials scenario. This report provides top line data relating to the clinical trials ... Read More
-
Plaque Psoriasis (Psoriasis Vulgaris) - Global Clinical Trials Review, 2024
Plaque Psoriasis (Psoriasis Vulgaris) - Global Clinical Trials Review, 2024 Summary GlobalData's clinical trial report, “Plaque Psoriasis (Psoriasis Vulgaris) - Global Clinical Trials Review, 2024 provides an overview of Plaque Psoriasis (Psoriasis Vulgaris) Clinical trials scenario. This report pro ... Read More
-
Social Anxiety Disorder (SAD/Social Phobia) - Global Clinical Trials Review, 2024
Social Anxiety Disorder (SAD/Social Phobia) - Global Clinical Trials Review, 2024 Summary GlobalData's clinical trial report, “Social Anxiety Disorder (SAD/Social Phobia) - Global Clinical Trials Review, 2024 provides an overview of Social Anxiety Disorder (SAD/Social Phobia) Clinical trials scenari ... Read More
-
Sicca Syndrome (Sjogren) - Global Clinical Trials Review, 2024
Sicca Syndrome (Sjogren) - Global Clinical Trials Review, 2024 Summary GlobalData's clinical trial report, “Sicca Syndrome (Sjogren) - Global Clinical Trials Review, 2024 provides an overview of Sicca Syndrome (Sjogren) Clinical trials scenario. This report provides top line data relating to the cli ... Read More
-
Cystic Fibrosis - Global Clinical Trials Review, 2024
Cystic Fibrosis - Global Clinical Trials Review, 2024 Summary GlobalData's clinical trial report, “Cystic Fibrosis - Global Clinical Trials Review, 2024 provides an overview of Cystic Fibrosis Clinical trials scenario. This report provides top line data relating to the clinical trials on Cystic Fibr ... Read More
-
KYORIN Pharmaceutical Co Ltd (4569) - Financial and Strategic SWOT Analysis Review
KYORIN Pharmaceutical Co Ltd (4569) - Financial and Strategic SWOT Analysis Review - provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths an ... Read More
-
Towa Pharmaceutical Co Ltd (4553) - Financial and Strategic SWOT Analysis Review
Towa Pharmaceutical Co Ltd (4553) - Financial and Strategic SWOT Analysis Review - provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and ... Read More
-
Cipla Ltd (CIPLA) - Financial and Strategic SWOT Analysis Review
Cipla Ltd (CIPLA) - Financial and Strategic SWOT Analysis Review - provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and t ... Read More
-
GlaxoSmithKline Pharmaceuticals Ltd (GLAXO) - Financial and Strategic SWOT Analysis Review
GlaxoSmithKline Pharmaceuticals Ltd (GLAXO) - Financial and Strategic SWOT Analysis Review - provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key stre ... Read More
-
Kaken Pharmaceutical Co Ltd (4521) - Financial and Strategic SWOT Analysis Review
Kaken Pharmaceutical Co Ltd (4521) - Financial and Strategic SWOT Analysis Review - provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and ... Read More
-
Jubilant Pharmova Ltd (JUBLPHARMA) - Financial and Strategic SWOT Analysis Review
Jubilant Pharmova Ltd (JUBLPHARMA) - Financial and Strategic SWOT Analysis Review - provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and ... Read More
-
Nanjing Pharmaceutical Co Ltd (600713) - Financial and Strategic SWOT Analysis Review
Nanjing Pharmaceutical Co Ltd (600713) - Financial and Strategic SWOT Analysis Review - provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths ... Read More
-
Nippon Shinyaku Co Ltd (4516) - Financial and Strategic SWOT Analysis Review
Nippon Shinyaku Co Ltd (4516) - Financial and Strategic SWOT Analysis Review - provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weak ... Read More
-
Aurobindo Pharma Ltd (AUROPHARMA) - Financial and Strategic SWOT Analysis Review
Aurobindo Pharma Ltd (AUROPHARMA) - Financial and Strategic SWOT Analysis Review - provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and ... Read More
-
Daiichi Sankyo Co Ltd (4568) - Financial and Strategic SWOT Analysis Review
Daiichi Sankyo Co Ltd (4568) - Financial and Strategic SWOT Analysis Review - provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakn ... Read More
-
Continuous Glucose Monitors Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2024 Update
Continuous Glucose Monitors Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2024 Update Summary GlobalData's Medical Devices sector report, “Continuous Glucose Monitors Pipeline Report including Stages of Development, Segments, Regi ... Read More
-
Orthopedic Prosthetics Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2024 Update
Orthopedic Prosthetics Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2024 Update Summary GlobalData's Medical Devices sector report, “Orthopedic Prosthetics Pipeline Report including Stages of Development, Segments, Region and Cou ... Read More
-
Celiac Disease: Competitive Landscape
Celiac Disease: Competitive Landscape Summary This reports provides a data-driven overview of the current and future competitive landscape in Celiac Disease therapeutics. In 2024, more than 3.7 million diagnosed prevalent cases of CD are anticipated in the 16 countries covered in GlobalData’s epidem ... Read More
-
UK Sector Series: Health & Beauty, 2023-2028
UK Sector Series: Health & Beauty, 2023-2028 Summary The UK Health & Beauty report offers a comprehensive insight into the Health & Beauty market in the UK, analysing the sector, the major players, the main trends, and consumer attitudes, as well as providing market forecasts out to 2028. The UK hea ... Read More
-
Focal Segmental Glomerulosclerosis: Competitive Landscape
Focal Segmental Glomerulosclerosis: Competitive Landscape Summary This reports provides a data-driven overview of the current and future competitive landscape in Focal Segmental Glomerulosclerosis therapeutics. In 2024, more than 36,000 diagnosed incident cases of FSGS are anticipated in the 16 coun ... Read More
-
Acute coronary syndrome: Competitive Landscape
Acute coronary syndrome: Competitive Landscape Summary This reports provides a data-driven overview of the current and future competitive landscape in Acute coronary syndrome therapeutics. In 2024, more than 7.8 million hospitalized incident cases of ACS are anticipated in the 16 countries covered i ... Read More
-
Epstein-Barr Virus: Competitive Landscape
Epstein-Barr Virus: Competitive Landscape Summary This reports provides a data-driven overview of the current and future competitive landscape in Epstein-Barr Virus therapeutics. In 2024, more than 700 million people are at risk of EBV infection in the 16 countries covered in GlobalData’s epidemiolo ... Read More
-
Saudi Pharmaceutical Industries & Medical Appliances Corp (2070) - Financial and Strategic SWOT Analysis Review
Saudi Pharmaceutical Industries & Medical Appliances Corp (2070) - Financial and Strategic SWOT Analysis Review - provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of t ... Read More
-
Hisamitsu Pharmaceutical Co Inc (4530) - Financial and Strategic SWOT Analysis Review
Hisamitsu Pharmaceutical Co Inc (4530) - Financial and Strategic SWOT Analysis Review - provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths ... Read More
Research Assistance
